Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2882 of 5804
-
Light and touch therapies tested for COVID-19 recovery
Symptom relief CompletedObjective: To compare low-level laser therapy and myofascial release in reducing inflammation and functional recovery in critically ill COVID-19 patients with 3-month home-based telerehabilitation assessment. Participants: One hundred two COVID-19 patients aged 45-60 years rando…
Phase: NA • Sponsor: Beni-Suef University • Aim: Symptom relief
Last updated Jun 27, 2026 08:14 UTC
-
Malaria drugs under watch: resistance study in kenya
Knowledge-focused CompletedThis implementation study evaluated the health systems feasibility, economic costs, and stakeholder acceptability of deploying multiple first-line therapies (MFTs) that were of the artemisinin-based combination therapies (ACTs) type, for uncomplicated malaria in Western Kenya. Th…
Sponsor: Strathmore University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Scientists hunt for clues to stop Late-Life depression from coming back
Knowledge-focused OngoingLate-life depression (LLD) is associated with disability, increased risk for cognitive decline and dementia, elevated suicide risk, and greater all-cause mortality. These outcomes are related to depression being a recurrent disorder, with repeated episodes over a patient's lifeti…
Sponsor: University of Illinois at Chicago • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:22 UTC
-
Shockwave showdown: which therapy eases heel pain best?
Symptom relief OngoingInflammation of the plantar fascia is known as plantar fasciitis and is commonly seen in active or overweight individuals. It can be treated via conservative or surgical therapies. Extracorporeal shockwave therapy has shown promise in the treatment of plantar fasciitis. Several s…
Phase: NA • Sponsor: Hospital for Special Surgery, New York • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Can your genes predict fatty liver complications?
Knowledge-focused Recruiting nowNAFLD is most frequently linked to excess adiposity, insulin resistance and cardiometabolic risk factors, it has become the leading cause of liver disease worldwide, and is associated with increased mortality due to multiple causes. HFC has a strong genetic component and the inve…
Phase: NA • Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Robotic suits and spinal zaps help paralyzed veterans take steps
Disease control CompletedSpinal cord injury (SCI) leads to several health-related consequences often linked to reduced levels of physical activity. Direct stimulation of the spinal cord, either through implanted devices or surface stimulation, has been combined with intense physical therapy assisted trea…
Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New antibody drug targets Hard-to-Treat cancers in first human trial
Disease control Recruiting nowIn this first-in-human, muticenter, non-randomized, open-label, standard 3+3 dose escalation Phase I study encompasses 5 parts (Part 1-5). The purpose of this FIH study is to evaluate the safety and tolerability profile of CBA-1205.
Phase: PHASE1 • Sponsor: Chiome Bioscience Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Brain training and exercise combo shows promise for mild memory loss
Symptom relief CompletedThe study aiming to investigate the efficacy, safety, and potential mechanism of a multimodal intervention on cognitive function in individuals with MCI or the cognitive normal elderly living in a community. The recruited elderly aged 50-75 years with normal cognitive function or…
Phase: NA • Sponsor: Huashan Hospital • Aim: Symptom relief
Last updated Jun 26, 2026 17:10 UTC
-
Home chemo shot study could free myeloma patients from hospital trips
Symptom relief Recruiting nowThis study is to see if the standard of care subcutaneous injection of bortezomib can safely be administered at home by the patient or caregiver. All tests and assessments are based on standard of care procedures.
Phase: PHASE2 • Sponsor: AHS Cancer Control Alberta • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
New scan may spare bladder cancer patients from surgery
Diagnosis CompletedTreatment of localized muscle invasive bladder cancer (MIBC) is radical cystectomy. Neoadjuvant chemotherapy (NAC) improves survival. Approximately 50-60% of all MIBC patients undergoing NAC before cystectomy are histopathological without remnant tumor in the cystectomy specimen…
Phase: NA • Sponsor: Jørgen Bjerggaard Jensen • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
COVID-19's hidden damage: new study scans heart, lungs, and brain
Knowledge-focused CompletedBackground: COVID-19 virus infection differs among people. Some people have no or mild symptoms. For others, COVID-19 is life threatening and causes damage to the body s organs. Researchers want to better understand the virus to learn how to kill it. Objective: To understand h…
Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Can extra antibiotics finally knock out MRSA in the throat?
Disease control CompletedThe aim of this study is to investigate the optimal way to treat MRSA throat carriers.
Phase: PHASE3 • Sponsor: Hvidovre University Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Diet showdown: can keto or mediterranean ease psoriasis and joint pain?
Symptom relief CompletedThe aim of our study is to compare the effectiveness of Mediterranean diet (MD) with the isocaloric Ketogenic diet (KD) on clinical and biochemical markers of inflammation in patients with obesity, psoriasis (PSO) and psoriatic arthritis (PsA).
Phase: NA • Sponsor: Attikon Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Stem cells aim to keep dialysis lifelines open
Disease control Recruiting nowResearchers are evaluating the safety of allogeneic Adipose Derived Mesenchymal Stem Cells (AMSC) use during hemodialysis arteriovenous fistula and arterial bypass creation and its efficacy on improving access maturation and primary anastomotic patency.
Phase: PHASE1 • Sponsor: Houssam Farres, M.D. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Bubble baby breakthrough? experimental cell shot aims to reboot immune system faster
Disease control CompletedThe purpose of this study is to evaluate the safety and the efficacy of Human T Lymphoid Progenitor (HTLP) injection to accelerate immune reconstitution after partially HLA compatible allogeneic hematopoietic stem cell transplantation in SCID patients.
Phase: PHASE1, PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Scientists probe immune system in severe COVID-19 to find new clues
Knowledge-focused Recruiting nowInfection with the SARS-CoV-2 coronavirus (COVID-19) has recently been identified as a pandemic due to the speed and global scale of its transmission. In Auvergne-Rhône-Alpes region (AURA), the epidemic began in February 2020 and the number of infected people is still important. …
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Genetic cheat code may unlock safer, stronger chemo cocktail for tough cancers
Disease control Recruiting nowThe purpose of the proposed study is to establish the safety of combining irinotecan chemotherapy with 5-FU, leucovorin/folinic acid, oxaliplatin, and docetaxel (abbreviated as the I-FLOAT study of gFOLFOXIRITAX) chemotherapies (leucovorin/folinic acid is a vitamin to make 5-FU w…
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New drug combo aims to outsmart Chemo-Resistant ovarian cancer
Disease control OngoingThis phase I trial studies the side effects and best dose of peposertib when given together with pegylated liposomal doxorubicin hydrochloride in treating patients with high or low grade ovarian cancer that has come back after a period of improvement (recurrent). Peposertib may s…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Cough medicine repurposed: ambroxol registry launches for rare brain diseases
Knowledge-focused Recruiting nowAmbroxol hydrochloride is an oral mucolytic drug available over-the-counter for many years as cough medicine. In 2009 it was found to also act as a pharmacological chaperone (PC) for mutant glucocerebrosidase, albeit in a several-fold higher dose. Unfortunately, due to its low co…
Sponsor: Shaare Zedek Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
New pill plus immunotherapy shows promise in early cancer trial
Disease control CompletedThis is a first-in-human Phase 1a/1b, multicenter, open-label, dose-escalation, dose and schedule optimization, and expansion study of TPST-1495 as a single agent and in combination with pembrolizumab to determine its maximum tolerated dose (MTD) and or recommended Phase 2 dose (…
Phase: PHASE1 • Sponsor: Tempest Therapeutics • Aim: Disease control
Last updated Jun 26, 2026 15:48 UTC